NOVAVAX INC Annual Costs and Expenses in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Novavax Inc quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
  • Novavax Inc Costs and Expenses for the quarter ending September 30, 2024 was $219M, a 30.1% decline year-over-year.
  • Novavax Inc Costs and Expenses for the twelve months ending September 30, 2024 was $1.19B, a 29.2% decline year-over-year.
  • Novavax Inc annual Costs and Expenses for 2023 was $1.55B, a 41% decline from 2022.
  • Novavax Inc annual Costs and Expenses for 2022 was $2.63B, a 7.28% decline from 2021.
  • Novavax Inc annual Costs and Expenses for 2021 was $2.83B, a 217% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.55B -$1.08B -41% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $2.63B -$206M -7.28% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $2.83B +$1.94B +217% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $892M +$753M +541% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $139M -$69M -33.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $208M +$5.32M +2.62% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $203M -$81.6M -28.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2016 $284M +$91M +47% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $193M +$79.1M +69.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
2014 $114M +$41M +55.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $73.3M +$21.6M +41.8% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $51.7M +$15.5M +42.7% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $36.3M -$2.57M -6.62% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $38.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.